Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giorgio Corti

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Plos One|May 26, 2010
The microcephalin ancestral allele in a Neanderthal individualMartina Lari, Ermanno Rizzi, Lucio Milani, et al.
Clinical Colorectal Cancer|April 15, 2019
A Genomic Analysis Workflow for Colorectal Cancer Precision OncologyGiorgio Corti, Alice Bartolini, Giovanni Crisafulli, et al.
Nature Communications|June 14, 2018
Reliance upon ancestral mutations is maintained in colorectal cancers that heterogeneously evolve during targeted therapiesMariangela Russo, Simona Lamba, Annalisa Lorenzato, et al.
Molecular Oncology|February 13, 2024
Preclinical efficacy of carfilzomib in BRAF-mutant colorectal cancer modelsFederica Maione, Daniele Oddo, Federica Galvagno, et al.
NPJ Precision Oncology|October 14, 2024
Prediction of homologous recombination deficiency identifies colorectal tumors sensitive to PARP inhibitionGiorgio Corti, Kristi Buzo, Enrico Berrino, et al.
Nature Communications|May 1, 2015
The molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targetsEnzo Medico, Mariangela Russo, Gabriele Picco, et al.
Molecular Oncology|March 12, 2024
Transcriptome-wide gene expression outlier analysis pinpoints therapeutic vulnerabilities in colorectal cancerElisa Mariella, Gaia Grasso, Martina Miotto, et al.
Cancer Cell|December 30, 2022
Genetic and pharmacological modulation of DNA mismatch repair heterogeneous tumors promotes immune surveillanceVito Amodio, Simona Lamba, Rosaria Chilà, et al.
Genome Medicine|June 30, 2019
Evolving neoantigen profiles in colorectal cancers with DNA repair defectsGiuseppe Rospo, Annalisa Lorenzato, Nabil Amirouchene-Angelozzi, et al.
Cancer Discovery|November 8, 2015
Acquired Resistance to the TRK Inhibitor Entrectinib in Colorectal CancerMariangela Russo, Sandra Misale, Ge Wei, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Plos One|May 26, 2010
The microcephalin ancestral allele in a Neanderthal individualMartina Lari, Ermanno Rizzi, Lucio Milani, et al.
Clinical Colorectal Cancer|April 15, 2019
A Genomic Analysis Workflow for Colorectal Cancer Precision OncologyGiorgio Corti, Alice Bartolini, Giovanni Crisafulli, et al.
Nature Communications|June 14, 2018
Reliance upon ancestral mutations is maintained in colorectal cancers that heterogeneously evolve during targeted therapiesMariangela Russo, Simona Lamba, Annalisa Lorenzato, et al.
Molecular Oncology|February 13, 2024
Preclinical efficacy of carfilzomib in BRAF-mutant colorectal cancer modelsFederica Maione, Daniele Oddo, Federica Galvagno, et al.
NPJ Precision Oncology|October 14, 2024
Prediction of homologous recombination deficiency identifies colorectal tumors sensitive to PARP inhibitionGiorgio Corti, Kristi Buzo, Enrico Berrino, et al.
Nature Communications|May 1, 2015
The molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targetsEnzo Medico, Mariangela Russo, Gabriele Picco, et al.
Molecular Oncology|March 12, 2024
Transcriptome-wide gene expression outlier analysis pinpoints therapeutic vulnerabilities in colorectal cancerElisa Mariella, Gaia Grasso, Martina Miotto, et al.
Cancer Cell|December 30, 2022
Genetic and pharmacological modulation of DNA mismatch repair heterogeneous tumors promotes immune surveillanceVito Amodio, Simona Lamba, Rosaria Chilà, et al.
Genome Medicine|June 30, 2019
Evolving neoantigen profiles in colorectal cancers with DNA repair defectsGiuseppe Rospo, Annalisa Lorenzato, Nabil Amirouchene-Angelozzi, et al.
Cancer Discovery|November 8, 2015
Acquired Resistance to the TRK Inhibitor Entrectinib in Colorectal CancerMariangela Russo, Sandra Misale, Ge Wei, et al.
Pageof 5